Financhill
Back

Avidity Biosciences Quote, Financials, Valuation and Earnings

Buy
66

RNA
Avidity Biosciences

Last Price:
29.51
Seasonality Move:
15.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Avidity Biosciences Price Quote

$29.51
+0.01 (+2.75%)
(Updated: May 18, 2024 at 5:52 AM ET)

Avidity Biosciences Key Stats

Buy
66
Avidity Biosciences (RNA) is a Buy

Day range:
$28.41 - $29.58
52-week range:
$4.83 - $30.54
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
209.50
P/B ratio:
3.4%

Volume:
895.4K
Avg. volume:
918.4K
1-year change:
167.94%
Market cap:
$2.8B
Revenue:
$9.6M
EPS:
$-2.96

How Much Does Avidity Biosciences Make?

Is Avidity Biosciences Growing As A Company?

  • What Is Avidity Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.59%
  • What Is Avidity Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Avidity Biosciences Stock Price Performance

What Is Avidity Biosciences 52-Week High & Low?

Avidity Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Avidity Biosciences?

Is Avidity Biosciences Cash Flow Positive?

  • What Is RNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$140.5M
  • What Is Avidity Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $460.3M
  • What Is Avidity Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $32.9M

Avidity Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    RNA return on invested capital is -38.54%
  • What Is Avidity Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -33.85%
  • What Is RNA Return On Equity?
    ROE is a measure of profitability and is -38.54%

Avidity Biosciences Earnings Date & Stock Price

Avidity Biosciences Competitors

Avidity Biosciences Dividend Yield

Data Unavailable

Avidity Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 9.79%
Revenue: 58.67% 37.85%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 45.25
Upside from Last Price: 53.39%

Major Shareholders

  • How many RNA shares are owned by institutional investors?
    150.9M RNA shares are owned by institutional investors
  • How many RNA shares are owned by insiders?
    286.7K RNA shares are owned by insiders